Antibodies useful in passive influenza immunization

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10654915
APP PUB NO 20140322210A1
SERIAL NO

14363297

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Specific monoclonal antibodies and fragments including bispecific antibodies thereof that are crossreactive with multiple clades of influenza virus including both Group 1 and Group 2 representatives are disclosed. These antibodies are useful in controlling influenza epidemics and pandemics as well as in providing prophylactic or therapeutic protection against seasonal influenza.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TRELLIS BIOSCIENCE LLC702 MARSHALL ST SUITE 614 REDWOOD CITY CA 94063

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ellsworth, Stote Palo Alto, US 6 20
Kauvar, Lawrence M San Francisco, US 100 1197
McCutcheon, Krista Maureen Burlingame, US 6 5
Park, Minha Brisbane, US 11 56
Usinger, William Lafayette, US 6 135

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 19, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 19, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00